NFKB1 and breast carcinoma: Indeed, we have previously demonstrated that ATM is required for DNA damage-induced activation of p65/p50 in breast cancer cells [7], and in CLL cells ATM interacts with the TCL1 oncogene to activate NF-κB [8].